Sign In
Buy WRD
$6.32
+0.0200 (+0.317%)
At Close: Aug 10, 2026
TSLA: Cathie Wood Dumps Millions in Tesla and Meta Shares
10:11am, Friday, 05'th Dec 2025
Cathie Wood shifted several positions across her ARK ETFs on Dec. 4, moving money out of two Mega tech names and into mid-cap growth stocks.ARK sold 14,211 shar
Cathie Wood-Led Ark Invest Bets $1.74 Million On This Robotaxi Stock As Driverless Revolution Accelerates
09:24pm, Wednesday, 03'rd Dec 2025
Cathie Wood's Ark Invest buys WeRide Inc. shares, showing confidence in the company's advancements in driverless vehicles. Stock closes at $9.12 with 5.19% increase. Other key trades include GeneDx, I
Ross Gerber Says Uber Is 'Cooked' Amid Waymo's San Francisco Expansion: 'Uber Drivers Better Start…'
12:54am, Monday, 01'st Dec 2025
Ross Gerber predicts Waymo's expansion in San Francisco could challenge Uber if the ride-hailing giant's drivers do not do this one thing.
Chinese President Xi Jinping emphasized progress in U.S.-China trade relations after speaking with President Donald Trump, following reports the U.S. may allow Nvidia (NASDAQ: NVDA) to resume AI chip
Robotaxi Rollout Is Paying Off For WeRide
08:14am, Friday, 28'th Nov 2025
The driverless technology company is enjoying a payoff from expanding its global taxi fleet, with quarterly revenues surging and losses continuing to shrink
WeRide And Uber Roll Out Driverless Rides In Abu Dhabi
05:26am, Wednesday, 26'th Nov 2025
WeRide Inc. and Uber Technologies Inc. launched fully driverless robotaxi commercial operations in Abu Dhabi, the first outside the US.
Stock Market Today: Dow Jones, S&P 500 Future Rise Ahead Of Thanksgiving Holiday—Dell Technologies, Autodesk, Uber In Focus
05:13am, Wednesday, 26'th Nov 2025
U.S. stock futures rose on Wednesday after Tuesday's advances. Futures of major benchmark indices were higher. The three-day winning streak comes amid a holiday-shortened week, as the markets will be
Uber, WeRide launch driverless robotaxis in Abu Dhabi
02:57am, Wednesday, 26'th Nov 2025
Uber Technologies rolled out driverless robotaxis in Abu Dhabi in partnership with Chinese autonomous-driving firm WeRide on Wednesday, following the tie-up they announced last year.
WeRide and Uber Launch Middle East's First Fully Driverless Robotaxi Commercial Operations in Abu Dhabi, UAE
02:00am, Wednesday, 26'th Nov 2025
ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--WeRide (NASDAQ: WRD, HKEX: 0800.HK), a global leader in autonomous driving technology, and Uber Technologies, Inc. (NYSE: UBER) today announced the la
From Science Project to Solvent: WeRide's 761% Revenue Surge
05:49pm, Tuesday, 25'th Nov 2025
For years, the autonomous vehicle (AV) sector has been defined by a frustrating narrative of high cash burn and distant promises. Investors have watched billions of dollars vanish into research and de
Pony AI Q3 Preview: LiDAR Trouble, Fleet Expansion And More—Key Factors That You Must Know
04:12am, Tuesday, 25'th Nov 2025
Ahead of Pony AI's Q3 earnings call, here are some key factors about the Robotaxi company you need to be aware of.
WeRide: This Ride Is Getting Safer
02:53pm, Monday, 24'th Nov 2025
WeRide Inc. reported strong Q3 2025 results, with revenue up significantly and a robust net cash position, reducing risk. WRD's global autonomous vehicle fleet and robotaxi operations are expanding ra
WeRide Inc. (WRD) Q3 2025 Earnings Call Transcript
01:23pm, Monday, 24'th Nov 2025
WeRide Inc. ( WRD ) Q3 2025 Earnings Call November 24, 2025 8:00 AM EST Company Participants Xu Han - Founder, Chairman & CEO Xuan Li - CFO & Head of International Conference Call Participants Tim Hsi
WeRide (WRD) Reports Strong Q3 Results with Significant Revenue Growth
12:14pm, Monday, 24'th Nov 2025
WeRide (WRD) experienced a significant increase in stock value after announcing its Q3 financial results. The autonomous driving company reduced its loss to RMB
U.S. stock futures rose on Monday after Friday's advances. Futures of major benchmark indices were higher. Optimism among investors is rising following New York Fed President John Williams' indication
